Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

A Novel Variant inCDKN1CIs Associated With Intrauterine Growth Restriction, Short Stature, and Early-Adulthood-Onset Diabetes

(2014) Sarah L. Kerns et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

CDK inhibitor p57Kip2is downregulated by Akt during HER2-mediated tumorigenicity

(2013) Ruiying Zhao et al.   CELL CYCLE

IMAGe syndrome: clinical and genetic implications based on investigations in three Japanese patients

(2013) Fumiko Kato et al.   CLINICAL ENDOCRINOLOGY

CDKN1Cmutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome

(2013) F Brioude et al.   JOURNAL OF MEDICAL GENETICS

Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome

(2013) Naoki Hamajima et al.   PLoS One

CDK inhibitor p57Kip2is negatively regulated by COP9 signalosome subunit 6

(2012) Bo Chen et al.   CELL CYCLE

Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome

(2012) Valerie A Arboleda et al.   NATURE GENETICS

CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1Cdt2Pathway during S Phase and after UV Irradiation

(2008) Hideo Nishitani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY